190
Participants
Start Date
November 30, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
A3309
A3309 in three different dosage levels or placebo once daily for the duration of the study
Albireo Investigative Site, Great Neck
Albireo Investigative Site, Levittown
Albireo Investigative Site, Hollywood
Albireo Investigative Site, Baltimore
Albireo Investigative Site, Annapolis
Albireo Investigative Site, Lynchburg
Albireo Investigative Site, Winston-Salem
Albireo Investigative Site, Greensboro
Albireo Investigative Site, Harrisburg
Albireo Investigative Site, Charlotte
Albireo Investigative Site, Statesville
Albireo Investigative Site, Anderson
Albireo Investigative Site, Boynton Beach
Albireo Investigative Site, Inverness
Albireo Investigative Site, Huntsville
Albireo Investigative Site, Chattanooga
Albireo Investigative Site, Kingsport
Albireo Investigative Site, Cincinnati
Albireo Investigative Site, Cincinnati
Albireo Investigative Site, Dayton
Albireo Investigative Site, Chesterfield
Albireo Investigative Site, Clive
Albireo Investigative Site, Davenport
Albireo Investigative Site, La Crosse
Albireo Investigative Site, Peoria
Albireo Investigative Site, Mission
Albireo Investigative Site, Overland Park
Albireo Investigative Site, Shreveport
Albireo Investigative Site, Monroe
Albireo Investigative Site, Oklahoma City
Albireo Investigative Site, Longview
Albireo Investigative Site, San Antonio
Albireo Investigative Site, El Paso
Albireo Investigative Site, Colorado Springs
Albireo Investigative Site, Salt Lake City
Albireo Investigative Site, Ogden
Albireo Investigative Site, Phoenix
Albireo Investigative Site, Chandler
Albireo Investigative Site, Albuquerque
Albireo Investigative Site, Henderson
Albireo Investigative Site, Encinitas
Albireo Investigative Site, San Diego
Albireo Investigative Site, Anaheim
Albireo Investigative Site, Marlton
Lead Sponsor
Albireo
INDUSTRY